Last update 10 May 2025

CLR-325

Overview

Basic Info

Drug Type
Biological products
Synonyms
CLR 325, CLR325
Target
APLNR
Action
agonists
Mechanism
APLNR agonists(Apelin receptor agonists)
Therapeutic Areas
Cardiovascular Diseases
Active Indication-
Inactive Indication
Heart Failure
Originator Organization
Novartis AGNovartis AG
Active Organization-
Inactive Organization
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CLR-325
NCT02696967
/ CompletedPhase 2
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
100 Clinical Results associated with CLR-325
Login to view more data
100 Translational Medicine associated with CLR-325
Login to view more data
100 Patents (Medical) associated with CLR-325
Login to view more data
100 Deals associated with CLR-325
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Heart FailurePhase 2
United States
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
17 May 2016
Heart FailurePhase 2
Belgium
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
17 May 2016
Heart FailurePhase 2
Germany
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
17 May 2016
Heart FailurePhase 2
Netherlands
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
17 May 2016
Heart FailurePhase 2
Singapore
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
17 May 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT02696967 (CTgov)
Phase 2
Heart Failure
26
Placebo
xyrqgtxmxp = mraczhvwpj xawyansidg (oghvbwkqvq, jvzdcdxjjq - ghqbcpxwmj)
View more
-
04 Mar 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free